Testing effectiveness (Phase 2)WithdrawnNCT01055301
What this trial is testing
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network